Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

980
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
980
Autoimmune Disorders01:29

Autoimmune Disorders

323
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
323
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

554
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
554

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The typical and atypical spectrum of subclinical rhythmic EEG discharges in adults and its electrical origin.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026
Same author

Outcomes of Early Versus Later Anticoagulation in Asian Atrial Fibrillation-Related Stroke: ELAN Subgroup Analysis.

Journal of stroke·2026
Same author

Cryptogenic Young Stroke Associated With Bilateral Pulmonary Arteriovenous Malformations.

Heart, lung & circulation·2026
Same author

Prevalence and risk factors of cognitive impairment among stroke survivors in India: an analysis of cross-sectional data from the Longitudinal Ageing Study in India.

BMJ open·2026
Same author

Comparison of primary and secondary stroke outcomes between government and private healthcare institutions: insights from the SPRINT India trial.

Frontiers in stroke·2026
Same author

Association of P2Y12 G52T genetic polymorphism with recurrent thromboembolic events in stroke and myocardial infarction patients on clopidogrel therapy: a prospective observational study.

Scientific reports·2026

Related Experiment Video

Updated: May 13, 2025

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.4K

Autoimmune encephalitis with autoimmune myocarditis.

Anuraag Gattu1, Chirag Sunil Lalwani2, Sudheeran Kannoth3

  • 1Amrita Institute of Medical Sciences and Research Centre, Kochi, Kerala, India.

BMJ Case Reports
|April 15, 2025
PubMed
Summary

This study highlights a rare case of autoimmune encephalitis and myocarditis in an elderly man. Treatment with intravenous immunoglobulin improved both neurological and cardiac symptoms, suggesting a link.

Keywords:
AutoimmunityImmunologyNeurology

More Related Videos

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
26:48

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis

Published on: July 4, 2007

17.9K
Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
08:47

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

23.5K

Related Experiment Videos

Last Updated: May 13, 2025

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.4K
Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
26:48

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis

Published on: July 4, 2007

17.9K
Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
08:47

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

23.5K

Area of Science:

  • Neurology
  • Cardiology
  • Immunology

Background:

  • Autoimmune encephalitis and autoimmune myocarditis are distinct conditions.
  • Concurrent presentation is rare, posing diagnostic challenges.
  • The case involves an elderly male with pre-existing comorbidities.

Purpose of the Study:

  • To report an uncommon case of co-occurring autoimmune encephalitis and autoimmune myocarditis.
  • To investigate the potential association between these conditions.
  • To evaluate treatment response in such a complex presentation.

Main Methods:

  • Clinical presentation and history review.
  • Neuroimaging (MRI brain) and cerebrospinal fluid analysis.
  • Systemic evaluation including Whole-body PET-CT and echocardiography.
  • Serological testing for specific antibodies (acetylcholine receptor).
  • Therapeutic intervention with intravenous immunoglobulin.

Main Results:

  • Patient presented with altered mental status, neurological deficits, and cardiac dysfunction.
  • Initial investigations for infection were negative for improvement.
  • Positive acetylcholine receptor antibody confirmed autoimmune etiology.
  • Intravenous immunoglobulin therapy led to significant improvement in both sensorium and cardiac function.

Conclusions:

  • Autoimmune encephalitis and autoimmune myocarditis can co-occur.
  • Acetylcholine receptor antibodies may play a role in both neurological and cardiac manifestations.
  • Intravenous immunoglobulin is a potential therapeutic option for this rare combined condition.